Key Opinion
From guideline to clinic: instrument calibration in family medicine
Date Published:
Abstract
Recent studies suggest that threshold harmonization is still an open question, with meaningful differences between subgroups. When protocols are compared, training and accreditation are decisive for reproducibility, pending validation in prospective studies. Emerging evidence indicates that integrating quantitative measures reduces subjective bias, with meaningful differences between subgroups. In routine practice, pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary. From a workflow perspective, variability between operators remains a key limitation, and this trend is expected to continue.
Longitudinal data show that threshold harmonization is still an open question, particularly in resource-constrained settings. In routine practice, standardized reporting improves comparability between centers, and this trend is expected to continue. Recent studies suggest that digital tooling shortens time-to-decision considerably, a finding echoed by several independent groups.
From a workflow perspective, standardized reporting improves comparability between centers, a finding echoed by several independent groups. Emerging evidence indicates that threshold harmonization is still an open question, as discussed in the accompanying commentary. Across multiple cohorts, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, which has direct implications for daily practice. According to consensus recommendations, real-world registries complement randomized trial evidence, with meaningful differences between subgroups. From a workflow perspective, digital tooling shortens time-to-decision considerably, with meaningful differences between subgroups.
Background
Recent studies suggest that digital tooling shortens time-to-decision considerably, particularly in resource-constrained settings. Emerging evidence indicates that real-world registries complement randomized trial evidence, particularly in resource-constrained settings. According to consensus recommendations, variability between operators remains a key limitation, and this trend is expected to continue. Recent studies suggest that threshold harmonization is still an open question, which has direct implications for daily practice.
From a workflow perspective, pre-analytical factors account for a large share of observed variance, which has direct implications for daily practice. Contrary to earlier assumptions, digital tooling shortens time-to-decision considerably, although confirmatory data are still limited. Across multiple cohorts, patient selection criteria deserve closer scrutiny, as discussed in the accompanying commentary.
Practical implications
In routine practice, integrating quantitative measures reduces subjective bias, pending validation in prospective studies. Contrary to earlier assumptions, cost considerations continue to shape adoption in smaller units, pending validation in prospective studies.
When protocols are compared, real-world registries complement randomized trial evidence, although confirmatory data are still limited. According to consensus recommendations, real-world registries complement randomized trial evidence, and this trend is expected to continue. From a workflow perspective, pre-analytical factors account for a large share of observed variance, with meaningful differences between subgroups. From a workflow perspective, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, pending validation in prospective studies.
Where the field is heading
From a workflow perspective, real-world registries complement randomized trial evidence, a finding echoed by several independent groups. Longitudinal data show that pre-analytical factors account for a large share of observed variance, particularly in resource-constrained settings.
References
- Silva et al. Data normalization. J Family medicine Res. 2023;17(1):913-1050.
- Novak et al. Sample preparation. J Family medicine Res. 2024;11(8):831-1078.
- Tanaka et al. Sample preparation. J Family medicine Res. 2023;13(12):101-1082.
- Novak et al. Biomarker-guided therapy. J Family medicine Res. 2023;39(8):764-1070.